Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development

25 Jul 2019

Abstract excerpt

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease in young children and a substantial contributor to respiratory tract disease throughout life and as such a high priority for vaccine development. However, after nearly 60 years of research no vaccine is yet available. The challenges to developing an RSV vaccine include the young age, 2-4 months of age, for the peak of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neonatal Respiratory Health Research
Share to Pneumonia and Respiratory Infections
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31402910
DOI: 10.3389/fimmu.2019.01675

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine DevelopmentPMID 31402910Read ↗

Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics.Semantic proximity Read ↗

RSV--a substantial slice of the airway disease burden and the way to a vaccine.Semantic proximity Read ↗

The long road to protect infants against severe RSV lower respiratory tract illnessSemantic proximity Read ↗

Delineating RSV-A and RSV-B: Epidemiological Patterns, Diagnostics, Clinical Severity, and Preventive Approaches.Semantic proximity Read ↗

A Safe and Effective Mucosal RSV Vaccine Consisting of RSV Phosphoprotein and Flagellin VariantSemantic proximity Read ↗

Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection.Semantic proximity Read ↗

Immunomodulation in Respiratory Syncytial Virus Infection: Mechanisms, Therapeutic Targets, and Clinical ImplicationsSemantic proximity Read ↗

A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant.Semantic proximity Read ↗

Factors Affecting the Immunity to Respiratory Syncytial Virus: From Epigenetics to Microbiome.Semantic proximity Read ↗

The rhinovirus puzzle: Linking virus and host factors to childhood asthma.Semantic proximity Read ↗

The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine CandidateSemantic proximity Read ↗

Clinical and biological consequences of respiratory syncytial virus genetic diversitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.